Full-Time

Client Services Manager

Clinical Trial

Prolaio

Prolaio

51-200 employees

Real-time cardiovascular care analytics platform

Compensation Overview

$115k/yr

+ Performance bonus + Equity

Chicago, IL, USA

Hybrid

Hybrid role based in the Chicagoland or Bay Area; the posting also mentions a Bay Area location not included in the raw ATS location.

Bachelor's

Category
Customer Experience & Support (2)
,
Required Skills
CRM
Data Analysis

Get referred to Prolaio

See people who can refer or advise you

Requirements
  • A Bachelor's degree in business, life sciences, health science, or directly applicable work experience.
  • At least 7 years of client management and/or project management experience, preferably in clinical trial management.
  • Knowledge of drug development lifecycles and relevant guidelines and requirements.
  • Experience working with clinical research stakeholders, including sponsors, contract research organizations, vendors, sites, and clinical research associates.
  • At least two years of experience as a client or project lead, with a demonstrated track record of developing strong relationships, providing exceptional customer service, driving issue resolution, and identifying opportunities to grow accounts.
  • Strong communication skills, including writing clear and concise messages, presenting material clearly, and listening to understand partner needs.
  • Demonstrated problem-solving skills and the ability to analyze data to identify opportunities and issues.
  • Demonstrated negotiation and conflict resolution skills.
  • At least two years of experience working on contracting, pricing proposals, and budgets from either the provider or client side.
  • Knowledge of Google Suite, customer relationship management systems, and project management tools.
  • Willingness to accept and advocate for new innovations.
Responsibilities
  • Serve as the primary client contact and provide exceptional service and guidance to create long-term relationships with key organizational stakeholders.
  • Develop strong internal relationships to resolve client issues collaboratively and promptly, lead internal client project teams, and advocate for the client.
  • Identify and assess new business opportunities and understand the client's pipeline, development strategy, and objectives.
  • Support contract scoping, negotiation, pricing, and terms.
  • Conduct client onboarding and develop and lead training for clients and internal partners.
  • Lead and document meetings and work to ensure deliverables, timeframes, and budgets are met.
  • Develop, generate, and present reports on programs and services provided.
  • Work closely with colleagues and clients to align solutions with business needs.
  • Address complex challenges and contribute to continuous improvement initiatives.
Desired Qualifications
  • Clinical trial management experience.

Prolaio provides a cardiovascular-focused health tech platform that helps healthcare providers improve patient outcomes through real-time data analytics and continuous monitoring. It collects data from electronic health records, patient surveys, and wearable sensors to build predictive models that warn care teams about potential health issues before they become critical. Healthcare providers access the platform via a subscription, giving them real-time analytics, alerts, and evidence-based care planning tools to monitor patients and optimize treatments. The company differentiates itself by concentrating on cardiovascular care and enabling continuous learning, patient engagement, and collaboration with pharmaceutical companies and research institutions to support new therapies. The overall goal is to reduce hospital admissions and readmissions while delivering timely, data-driven care that keeps patients healthier.

Company Size

51-200

Company Stage

Early VC

Total Funding

$25.5M

Headquarters

Scottsdale, Arizona

Founded

2022

Get referred to Prolaio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Kardigan says Prolaio speeds 2026 readouts across three late-stage cardiovascular programs.
  • The platform collects daily physiologic data from wearable sensors and clinic records.
  • Management says Prolaio improves trial efficiency and raises clinical success probability.

What critics are saying

  • Prolaio lost independence in 2025, so roles depend on Kardigan’s strategy.
  • Kardigan reported no revenue through March 31, 2026, funding everything from investors.
  • If Kardigan’s trials fail, Prolaio becomes a sunk cost with limited standalone demand.

What makes Prolaio unique

  • Prolaio combines FDA-cleared monitoring with cardiovascular analytics and real-world data.
  • Kardigan acquired Prolaio in February 2025, keeping the platform inside a therapeutics company.
  • Its platform supports smaller, faster cardiovascular trials using continuous remote monitoring.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Stock Options

Company Equity

Retirement Plan: 401(k) plan

Paid Time Off

Growth & Insights and Company News

Headcount

6 month growth

-8%

1 year growth

-6%

2 year growth

-4%
Business Wire
Mar 28th, 2025
Kardigan Acquires Prolaio to Create a Pioneering Heart Health Company with One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform

Kardigan, a heart health company modernizing cardiovascular (CV) drug development, announced today that it has acquired Prolaio, a clinical intelligence comp...

U.S. Securities and Exchange Commission
Sep 13th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.